Compare PPCB & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PPCB | RCON |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | Australia | China |
| Employees | N/A | N/A |
| Industry | | Oilfield Services/Equipment |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1M | 18.7M |
| IPO Year | 2011 | 2008 |
| Metric | PPCB | RCON |
|---|---|---|
| Price | $1.65 | $0.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 125.5K | 52.5K |
| Earning Date | 11-24-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,430,788.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.06 | $0.02 |
| 52 Week High | $6.79 | $6.42 |
| Indicator | PPCB | RCON |
|---|---|---|
| Relative Strength Index (RSI) | 64.85 | 44.69 |
| Support Level | $1.23 | $0.88 |
| Resistance Level | $1.98 | $1.06 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 58.65 | 45.61 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Recon Technology Ltd is provide oilfield specialized equipment, automation systems, tools, chemicals and field services to petroleum companies mainly in the PRC. It has four operating segments automation product and software, equipment and accessories, oilfield environmental protection and platform outsourcing services. Majority of revenue comes from Automation product and software segment.